About 68% cases of oral leukoplakia in our study exhibited both PD-L1 and PD-1 expression, which provide a new interpretation of precancerous lesions in terms of tumour immunology, showing that these lesions represent the equilibrium phase as defined by the concept of cancer immunoediting. This evidence concerns the gene RPL17 and Oral leukoplakia.